Bo Xu

25PUBLICATIONS
6CO-AUTHORS
Cancer diagnosisPharmacogenomicsRespiratory diseasesMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 17, 2026
Energetic Decoding of VSMC Plasticity: Metabolic Reprogramming and Phenotypic Switching.

|Sep 11, 2026
Assessing the Association Between GLP-1 Receptor Agonists and Diabetic Foot Complications Using Real-World Pharmacovigilance Database and Mendelian Randomization.

|May 29, 2026
Complement C5 inhibitor crovalimab for the treatment of paroxysmal nocturnal hemoglobinuria.

|Feb 18, 2026
Explore the potential mechanisms between ertugliflozin and kidney cancer through bioinformatics analysis and Mendelian randomization study.

Bo Xu, Peng Xiang, Xiongwen Yang

|Sep 18, 2025
Association between SGLT2 inhibitors and genital cancer: a meta-analysis and mendelian randomization study.

Bo Xu, Yilin Liu, Zunbo He

|Jul 05, 2025
Role of the E26 transformation specific transcription factor family in metabolic disorders.

Mingxia Yang, Lili Gao, Bo Xu

Pageof 5

Frequent Collaborators

20 joint publications

Jiecan Zhou

6 joint publications

Tianqiao Zhang

1 joint publications

Peng Xiang

1 joint publications

Xifan Luo